| Financial Year |
March 31 2023 |
| Monetary Funds |
6,396,470,476.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
69,051,963.55 |
| Accounts Receivable |
125,087,283.14 |
| Advances to Suppliers |
236,748,595.36 |
| Other Receivables |
9,100,467.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,108,010,751.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
60,636,269.00 |
| Total Current Assets |
9,365,238,157.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
6,463,840,634.10 |
| Under-construction Projects |
583,263,021.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
192,342,532.18 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
29,098,404.65 |
| Deferred Income Tax Assets |
128,706,716.43 |
| Other Non-Current Assets |
99,733,196.59 |
| Sub-Total of Non-Current Assets |
7,505,547,796.73 |
| Total Assets |
16,870,785,954.67 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
33,150,776.49 |
| Notes Payable |
1,059,298,501.55 |
| Accounts Payable |
1,158,965,294.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
215,332,500.79 |
| Taxes Payable |
58,320,904.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
169,746,871.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
30,797,393.51 |
| Sub-Total of Current Liabilities |
2,962,515,269.68 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,680,887.56 |
| Deferred Income Tax Liabilities |
73,897,866.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
116,204,258.19 |
| Total Liabilities |
3,078,719,527.87 |
| Paid-In Capital(Or Share Stock) |
3,972,222,224.00 |
| Capital Surplus |
3,824,820,047.17 |
| Surplus Reserve |
953,821,670.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,040,849,132.73 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,792,066,426.80 |
| Owner's Equity（Stockholder's Equity） |
13,792,066,426.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
16,870,785,954.67 |
